動物遺伝学市場規模、シェア、動向、2031年までの世界予測

世界の動物遺伝学市場は、2026年に66億4,000万米ドルと評価され、予測期間中に年平均成長率（CAGR）7.1%で成長し、2031年には93億7,000万米ドルに達するとMarketsandMarketsでは予測しています。この成長は、高品質な動物性タンパク質や乳製品への需要拡大、家畜の生産性向上への関心の高まり、そしてゲノム選抜、SNPジェノタイピング、分子育種技術の導入拡大によって牽引されています。これらの技術は、生産量、繁殖能力、飼料効率、耐病性といった優れた形質の迅速な特定を可能にします。また、動物の健康、薬剤耐性、持続可能な畜産生産に対する懸念の高まりが、遺伝的改良プログラムの導入をさらに加速させています。さらに、AIを活用した表現型解析、精密畜産、性選別精液、胚関連技術の進歩が育種の精度向上と遺伝的改良の加速をもたらしているほか、新興国における家畜生産性向上のための政府の取り組みも市場の拡大を後押ししています。

調査対象範囲

本調査レポートでは、動物遺伝学市場を以下の区分で分類しています：生体動物（家禽、豚、牛、犬、その他）、製品・サービス（動物遺伝資源、動物遺伝子検査サービス）、技術（NGS、PCR、rDNA、マイクロアレイ、その他）、エンドユーザー（畜産農場、動物病院・診療所、診断センター、研究機関）、および地域。

詳細な分類（サブセグメント）については、本編レポートにてご確認いただけます。

また、本調査には主要企業に関する詳細な競合分析も含まれており、各社の企業概要、製品・事業内容に関する主要な知見、最近の動向、主要な市場戦略などが網羅されています。

本レポートを購入するメリット

本レポートは、市場のリーダー企業や新規参入企業に対し、動物遺伝学市場全体および各セグメントの収益に関する極めて精度の高い推定値を提供します。これにより、ステークホルダーは競争環境を把握し、自社の事業をより効果的に位置づけるための知見を得るとともに、適切な市場参入戦略を策定することが可能になります。さらに、市場の動向を理解する一助となるほか、市場を牽引する要因（ドライバー）、阻害要因、課題、および機会に関する情報も提供します。

本レポートでは、以下の点に関する知見を提供します。

主要な促進要因（高品質な動物性タンパク質や乳製品の消費拡大、動物の健康・生産性・繁殖効率の向上に向けた遺伝学の活用への関心の高まり、高度な遺伝子解析サービスによる遺伝性疾患の予防、家畜改良プログラムにおける分子・ゲノムツールの採用拡大）、阻害要因（高度な遺伝子検査に伴う高コストによる採用の制約、遺伝子検査技術の精度や結果解釈における技術的限界）、機会（発展途上国における未開拓の市場ポテンシャル、高度な表現型解析技術とゲノム選抜プログラムの統合、動物遺伝学研究および製品イノベーションへの投資拡大）、および課題（地域に適応した家畜集団を対象とした品種特有の遺伝的改良プログラムの開発、動物遺伝学専門家の技術的専門知識の不足）

• 製品開発・イノベーション：動物遺伝学市場における次世代技術、研究開発（R&D）活動、および新製品・新サービスの投入に関する詳細な情報。
• 市場開拓：有望な市場に関する包括的な情報（様々な地域における動物遺伝学市場の分析）。
• 市場の多角化：動物遺伝学市場における新製品・新サービス、未開拓地域、最近の動向、および投資に関する詳細な情報。
• 競争状況の評価：主要企業（Hendrix Genetics BV [オランダ]、Topigs Norsvin [オランダ]、Genus plc [英国]、URUS Group LP [米国]、CRV [オランダ]など）の市場シェア、成長戦略、および製品ラインナップに関する詳細な分析。

Report Description

The global animal genetics market was valued at USD 6.64 billion in 2026 and is projected to reach USD 9.37 billion by 2031, growing at a CAGR of 7.1% during the forecast period. This is driven by rising demand for high-quality animal protein and dairy products, increasing focus on livestock productivity, and growing adoption of genomic selection, SNP genotyping, and molecular breeding technologies. These solutions enable faster identification of superior traits such as improved yield, fertility, feed efficiency, and disease resistance. Growing concerns around animal health, antimicrobial resistance, and sustainable livestock production are further accelerating the adoption of genetic improvement programs. Additionally, advancements in AI-based phenotyping, precision livestock farming, sexed semen, and embryo technologies are enhancing breeding accuracy and accelerating genetic gains, while government initiatives to improve livestock productivity in emerging markets are supporting market expansion.

“Bovine embryos are expected to register the highest growth in the embryo market.”

The bovine embryos segment is projected to grow at the highest CAGR between 2026 and 2031 with wider implementation of embryo transfer and in vitro fertilization (IVF) techniques across cattle breeding programs. These technologies enable rapid multiplication and distribution of elite genetics from high-performing animals with desirable traits such as enhanced milk yield, improved growth characteristics, better fertility, feed efficiency, and disease resistance. The integration of genomic testing and embryo screening is improving selection precision by identifying embryos with superior genetic potential at an early stage. Expansion of commercial embryo production facilities, veterinary reproductive service providers, and specialized breeding networks is increasing accessibility to bovine embryo technologies. Additionally, standardized embryo evaluation practices and growing cross-border trade of high-value bovine embryos are strengthening genetic improvement initiatives worldwide.

“By end user, animal farms accounted for the largest share of the animal genetics market in 2025.”

Animal farms held the largest share of the end-user market in 2025, owing to their central role in the adoption of animal genetics solutions across livestock production systems. Farms are the primary users of genetic materials, including semen and embryos, as well as genetic testing and breeding services to improve productivity, animal health, and breeding efficiency. As genomic data and performance-based selection increasingly influence breeding decisions, farms continue to remain key contributors to demand for genetic improvement solutions across poultry, swine, and dairy operations. This segment is expected to maintain its leading position through 2031, supported by continued adoption of advanced breeding technologies and increasing focus on optimizing livestock performance.

Breakdown of Primaries

The study contains insights from various industry experts. The breakdown of the primaries is as follows:

• By Company Type: Tier 1 – 35%, Tier 2 – 40%, and Tier 3 – 25%
• By Designation: C-Level – 35%, Director Level – 25%, and Others – 40%
• By Region: North America – 40%, Europe – 25%, Asia Pacific – 20%, Middle East & Africa – 8%, Latin America – 7%

Hendrix Genetics BV (Netherlands), Topigs Norsvin (Netherlands), Genus plc (UK), URUS Group LP (US), CRV (Netherlands), Neogen Corporation (US), Eurofins Scientific (Luxembourg), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Select Sires Inc. (US), Groupe Grimaud (France), Zoetis Services LLC (US), Quantum Genetix/Biosciences (Canada), Animal Genetics, Inc. (US), and Semex (Canada).

Research Coverage

This research report categorizes the animal genetics market by live animal (poultry, porcine, bovine, canine, and other live animals), by product & service (animal genetic materials and animal genetic testing services), by technology (NGS, PCR, rDNA, microarrays, and other technologies), by end user (animal farms, veterinary hospitals & clinics, diagnostic centers, and research institutes), and by region.

Further type-level segmentation is available in the full report.

The study also includes an in-depth competitive analysis of the market’s key players, their company profiles, key observations related to product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report

The report will provide market leaders and new entrants with the closest approximations of revenue for the overall animal genetics market and its subsegments. It will help stakeholders understand the competitive landscape, gain insights to position their businesses more effectively, and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

Analysis of key drivers (increasing consumption of high-quality animal-derived protein and dairy products, rising focus on improving animal health, livestock productivity, and breeding efficiency through animal genetics, prevention of genetic diseases through advanced genetic services, growing adoption of molecular and genomic tools in livestock improvement programs), restraints (high cost associated with advanced genetic testing, limiting adoption of animal genetic services, technical limitations in accuracy and interpretation of genetic testing technologies), opportunities (untapped market potential in developing countries, integration of advanced phenotyping technologies with genomic selection programs, rising investments in animal genetics research and product innovation), and challenges (developing breed-specific genetic improvement programs for locally adapted animal populations, lack of technical expertise among animal genetics professionals)

• Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and new product and service launches in the animal genetics market.
• Market Development: Comprehensive information about lucrative markets—the report analyzes the animal genetics market across varied regions.
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the animal genetics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, including Hendrix Genetics BV (Netherlands), Topigs Norsvin (Netherlands), Genus plc (UK), URUS Group LP (US), and CRV (Netherlands)

Table of Contents

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 35
1.3.2 INCLUSIONS & EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 37
1.3.4 CURRENCY CONSIDERED 37
1.4 STAKEHOLDERS 38
1.5 SUMMARY OF CHANGE 38
2 EXECUTIVE SUMMARY 39
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 39
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 40
2.3 DISRUPTIVE TRENDS IN ANIMAL GENETICS MARKET 41
2.4 HIGH GROWTH SEGMENTS 42
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 43
3 PREMIUM INSIGHTS 44
3.1 ANIMAL GENETICS MARKET OVERVIEW 44
3.2 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY COUNTRY AND END USER 45
3.3 GEOGRAPHIC SNAPSHOT OF ANIMAL GENETICS MARKET 46
4 MARKET OVERVIEW 47
4.1 INTRODUCTION 47
4.2 MARKET DYNAMICS 47
4.2.1 DRIVERS 48
4.2.1.1 Increasing consumption of high-quality animal-derived protein and dairy products 48
4.2.1.2 Rising focus on improving animal health, livestock productivity and breeding efficiency through animal genetics 49
4.2.1.3 Prevention of genetic diseases through advanced genetic services 50
4.2.1.4 Growing adoption of molecular and genomic tools in livestock improvements 50
4.2.2 RESTRAINTS 51
4.2.2.1 High cost associated with advanced genetic testing limiting adoption of animal genetic services 51
4.2.2.2 Technical limitations in accuracy and interpretation of genetic
testing technologies 52

4.2.3 OPPORTUNITIES 52
4.2.3.1 Untapped market potential in developing countries 52
4.2.3.2 Integration of advanced phenotyping technologies with genomic selection programs 53
4.2.3.3 Rising investments in animal genetics research and
product innovation 54
4.2.4 CHALLENGES 54
4.2.4.1 Developing breed-specific genetic improvement programs for locally adapted animal populations 54
4.2.4.2 Lack of technical expertise among animal genetics professionals 55
4.3 UNMET NEEDS AND WHITE SPACES 56
4.3.1 UNMET NEEDS IN ANIMAL GENETICS MARKET 56
4.3.2 WHITE SPACE OPPORTUNITIES 57
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 58
4.4.1 INTERCONNECTED MARKETS 58
4.4.2 CROSS-SECTOR OPPORTUNITIES 58
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 59
5 INDUSTRY TRENDS 61
5.1 PORTER’S FIVE FORCES ANALYSIS 61
5.1.1 THREAT OF NEW ENTRANTS 62
5.1.2 THREAT OF SUBSTITUTES 63
5.1.3 BARGAINING POWER OF BUYERS 63
5.1.4 BARGAINING POWER OF SUPPLIERS 63
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 63
5.2 MACROECONOMIC INDICATORS 64
5.2.1 INTRODUCTION 64
5.2.2 GDP TRENDS & FORECAST 64
5.2.3 TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY 65
5.2.4 TRENDS IN GLOBAL ANIMAL MEDICAL DEVICE INDUSTRY 65
5.3 SUPPLY CHAIN ANALYSIS 66
5.4 VALUE CHAIN ANALYSIS 69
5.5 ECOSYSTEM ANALYSIS 71
5.6 PRICING ANALYSIS 72
5.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS,
BY PRODUCT & SERVICE MARKET (2023–2025) 72
5.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY MARKET 73
5.6.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END USER 73
5.6.4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION 74
5.7 TRADE ANALYSIS 75
5.7.1 TRADE DATA FOR HS CODE 051110 76
5.7.1.1 Import data for HS Code 051110 76
5.7.1.2 Export data for HS Code 051110 76
5.8 KEY CONFERENCES & EVENTS 77
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78
5.10 INVESTMENT & FUNDING SCENARIO 79
5.11 CASE STUDY ANALYSIS 80
5.12 IMPACT OF 2025 US TARIFFS – ANIMAL GENETICS MARKET 81
5.12.1 INTRODUCTION 81
5.12.2 KEY TARIFF RATES 81
5.12.3 PRICE IMPACT ANALYSIS 82
5.12.4 IMPACT ON COUTRY/REGION 83
5.12.5 IMPACT ON END-USE INDUSTRIES 84
5.12.5.1 Animal farms 84
5.12.5.2 Veterinary hospitals and clinics 84
5.12.5.3 Diagnostics center 84
5.12.5.4 Research center 85
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS AND FUTURE APPLICATIONS 86
6.1 KEY EMERGING TECHNOLOGIES 86
6.1.1 CRISPR-CAS9 GENE EDITING 86
6.1.2 PRECISION PHENOTYPING 86
6.2 COMPLEMENTARY TECHNOLOGIES 87
6.2.1 ARTIFICIAL INSEMINATION 87
6.2.2 EMBRYO TRANSFER TECHNOLOGY 88
6.3 ADJACENT TECHNOLOGIES 88
6.3.1 ARTIFICIAL INTELLIGENCE (AI) 88
6.3.2 PRECISION LIVESTOCK FARMING 89
6.4 TECHNOLOGY/PRODUCT ROADMAP 90
6.4.1 NEAR TERM (2025–2027) 90
6.4.2 MID-TERM (2028–2030) 91
6.4.3 LONG TERM (2030+) 92
6.5 PATENT ANALYSIS 93
6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS 94
6.6 FUTURE APPLICATIONS 97
6.6.1 PRECISION BREEDING AND GENOMIC SELECTION 97
6.6.2 DEVELOPMENT OF DISEASE-RESISTANT AND HEALTHIER ANIMAL BREEDS 97
6.6.3 CLIMATE-RESILIENT LIVESTOCK PRODUCTION 98
6.6.4 CONSERVATION AND RESTORATION OF VALUABLE ANIMAL
GENETIC RESOURCES 98
6.6.5 PERSONALIZED BREEDING PROGRAMS USING AI AND GENOMIC
DATA ANALYTICS 98

6.7 IMPACT OF AI/GENERATIVE AI ON ANIMAL GENETICS MARKET 98
6.7.1 TOP USE CASES AND MARKET POTENTIAL 99
6.7.2 BEST PRACTICES IN ANIMAL GENETICS MARKET 100
6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN ANIMAL GENETICS MARKET 100
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS – ANIMAL GENETICS MARKET 101
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE ANIMAL GENETICS 102
7 SUSTAINABILITY & REGULATORY LANDSCAPE 103
7.1 REGIONAL REGULATIONS & COMPLIANCE 103
7.1.1 REGULATORY ANALYSIS 103
7.1.1.1 North America 103
7.1.1.2 Europe 103
7.1.1.3 APAC 104
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
7.2 INDUSTRY STANDARDS 108
7.2.1 TESTING LABORATORY COMPETENCE STANDARD – ISO/IEC 17025:2017 108
7.2.2 QUALITY MANAGEMENT SYSTEM STANDARD – ISO 9001:2015 108
7.2.3 BIOBANKING OF ANIMAL GERMPLASM STANDARD – ISO 16677-1:2025 108
7.2.4 BIOTECHNOLOGY — BIOPROCESSING STANDARD – ISO 20688-1:2024 108
7.2.5 INFORMATION SECURITY MANAGEMENT STANDARD – ISO/IEC 27001:2022 108
7.3 SUSTAINABILITY INITIATIVES 109
7.3.1 SUSTAINABLE ANIMAL HEALTH AND GENETICS INNOVATION –
ZOETIS SERVICES LLC. 109
7.3.2 ADVANCING SUSTAINABILITY THROUGH ANIMAL GENETICS – GENUS PLC 109
7.3.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 109
7.3.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 110
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 112
8.1 DECISION-MAKING PROCESS 112
8.2 KEY STAKEHOLDERS & BUYING CRITERIA 114
8.2.1 BUYING CRITERIA 115
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 117
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 118
8.5 MARKET PROFITABILITY 119
9 ANIMAL GENETICS MARKET, BY LIVE ANIMAL 121
9.1 INTRODUCTION 122
9.2 BOVINE 123
9.2.1 INCREASING FOCUS ON MAXIMIZING PRODUCTION EFFICIENCY TO
DRIVE MARKET 123

9.3 PORCINE 125
9.3.1 INCREASING APPLICATION OF ADVANCED GENETIC TECHNIQUES TO AID MARKET GROWTH 125
9.4 CANINE 126
9.4.1 RISING AWARENESS OF GENETIC HEALTH IN DOGS TO SUPPORT GROWTH 126
9.5 POULTRY 128
9.5.1 RISING DEMAND FOR CHICKEN AND EGG AS PRIMARY PROTEIN SOURCES TO DRIVE MARKET 128
9.6 OTHER LIVE ANIMALS 129
10 ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE 131
10.1 INTRODUCTION 132
10.2 ANIMAL GENETIC MATERIALS 134
10.2.1 SEMEN 136
10.2.1.1 Bovine semen 137
10.2.1.1.1 Bovine semen to register highest growth rate during
study period 137
10.2.1.2 Porcine semen 140
10.2.1.2.1 Rising use of artificial insemination to propel market growth 140
10.2.1.3 Equine semen 141
10.2.1.3.1 Stringent regulations for disease control to pose challenges for equine industry breeders 141
10.2.1.4 Canine semen 143
10.2.1.4.1 Increasing adoption of dogs as companion animals to
drive market 143
10.2.1.5 Other animal semen 144
10.2.2 EMBRYOS 146
10.2.2.1 Bovine embryos 147
10.2.2.1.1 Growing popularity among seed stock and beef producers to support market growth 147
10.2.2.2 Equine embryos 149
10.2.2.2.1 Argentina, Brazil, and US to hold leading shares in embryo transfer technology 149
10.2.2.3 Other animal embryos 150
10.3 ANIMAL GENETIC TESTING SERVICES 152
10.3.1 GENETIC DISEASE TESTS 154
10.3.1.1 Genetic disease tests to witness highest growth in testing
services market 154
10.3.2 GENETIC TRAIT TESTS 156
10.3.2.1 Bovine genetic trait tests 157
10.3.2.1.1 Focus on high-productivity traits in herds to drive demand 157
10.3.2.2 Other genetic trait tests 158
10.3.3 DNA TYPING 160
10.3.3.1 Emphasis on parentage identification, animal registration, and gender-associated disease identification to propel market 160
10.3.4 OTHER SERVICES 161
11 ANIMAL GENETICS MARKET, BY TECHNOLOGY 163
11.1 INTRODUCTION 164
11.2 NGS (NEXT-GENERATION SEQUENCING) 165
11.2.1 INCREASING APPLICATIONS IN AND RISING GLOBAL DEMAND FOR CHICKEN AND EGGS TO SUPPORT GROWTH 165
11.3 PCR (POLYMERASE CHAIN REACTION) 167
11.3.1 COST-EFFECTIVENESS, SIMPLICITY, AND HIGH ACCURACY TO DRIVE MARKET 167
11.4 RDNA (RECOMBINANT DNA TECHNOLOGY) 168
11.4.1 ABILITY TO SUPPORT GENETIC ENGINEERING AND GMOS TO SUPPORT MARKET GROWTH 168
11.5 MICROARRAYS 170
11.5.1 RAPID ANALYTICAL CAPABILITIES TO PROPEL ADOPTION OF MICROARRAYS 170
11.6 OTHER TECHNOLOGIES 171
12 ANIMAL GENETICS MARKET, BY END USER 173
12.1 INTRODUCTION 174
12.2 ANIMAL FARMS 176
12.2.1 GROWING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO
DRIVE MARKET 176
12.3 VETERINARY HOSPITALS & CLINICS 178
12.3.1 RISING INVESTMENTS AND TECHNOLOGICAL ADVANCEMENTS TO
PROPEL GROWTHS 178
12.4 DAIGNOSTIC CENTERS 179
12.4.1 RISING DEMAND FOR ACCURATE AND TIMELY DIAGNOSIS TO SUPPORT MARKET GROWTH 179
12.5 RESEARCH INSTITUTES 181
12.5.1 INCREASED FUNDING FOR RESEARCH AND GOVERNMENT INITIATIVES TO DRIVE MARKET 181
13 ANIMAL GENETICS MARKET, BY REGION 183
13.1 INTRODUCTION 184
13.2 NORTH AMERICA 185
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 185
13.2.2 US 190
13.2.2.1 Adoption of advanced genetic testing methods to drive
growth of market 190
13.2.3 CANADA 194
13.2.3.1 Growing demand for genetic material to boost market growth 194

13.3 EUROPE 198
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 199
13.3.2 GERMANY 203
13.3.2.1 Growing adoption of genomic breeding and sustainable livestock production drives the animal genetics market 203
13.3.3 UK 207
13.3.3.1 Selective breeding programs and efforts to improve breed productivity to drive demand for animal genetics 207
13.3.4 FRANCE 210
13.3.4.1 Growing demand for livestock and poultry products drives the animal genetics market 210
13.3.5 ITALY 215
13.3.5.1 Government initiatives to conserve indigenous breeds and improve livestock productivity drive market growth 215
13.3.6 SPAIN 218
13.3.6.1 Rising demand for pork and poultry products supports the growth of the animal genetics market 218
13.3.7 NETHERLANDS 222
13.3.7.1 Strong livestock sector and growing presence of key market players to drive the animal genetics market 222
13.3.8 REST OF EUROPE 226
13.4 ASIA PACIFIC 229
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 229
13.4.2 CHINA 235
13.4.2.1 China to hold largest share of animal genetics market 235
13.4.3 INDIA 239
13.4.3.1 Large dairy cattle population and increasing demand for superior genetics drive market growth 239
13.4.4 JAPAN 243
13.4.4.1 Increased production and consumption of livestock products to drive market growth 243
13.4.5 AUSTRALIA 246
13.4.5.1 Increasing demand for animal-derived food products to propel market growth 246
13.4.6 SOUTH KOREA 250
13.4.6.1 Growing demand for premium animal protein and advanced breeding technologies drive market growth 250
13.4.7 REST OF ASIA PACIFIC 254
13.5 LATIN AMERICA 257
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 257
13.5.2 BRAZIL 261
13.5.2.1 Brazil to hold largest share of LATAM market 261
13.5.3 MEXICO 265
13.5.3.1 High demand for animal meat to drive market growth in Mexico 265
13.5.4 REST OF LATIN AMERICA 269
13.6 MIDDLE EAST & AFRICA 272
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 273
13.6.2 GCC COUNTRIES 277
13.6.2.1 Emphasis on improving animal welfare standards to support market demand 277
13.6.2.2 Kingdom of Saudi Arabia 281
13.6.2.2.1 Kingdom of Saudi Arabia to hold the largest share of the Middle East Animal genetics market 281
13.6.2.3 United Arab Emirates 284
13.6.2.3.1 Growing adoption of animal genetics technologies in UAE 284
13.6.2.4 Rest of GCC Countries 288
13.6.3 REST OF MIDDLE EAST AND AFRICA 291
14 COMPETITIVE LANDSCAPE 295
14.1 INTRODUCTION 295
14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2024–2026 295
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
ANIMAL GENETICS MARKET 296
14.3 REVENUE ANALYSIS, 2023–2025 297
14.3.1 ANIMAL GENETICS MARKET: REVENUE ANALYSIS 297
14.4 MARKET SHARE ANALYSIS, 2025 298
14.4.1 GLOBAL SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025) 298
14.4.2 US: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025) 300
14.4.3 EUROPE: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025) 301
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 302
14.5.1 STARS 302
14.5.2 EMERGING LEADERS 302
14.5.3 PERVASIVE PLAYERS 302
14.5.4 PARTICIPANTS 302
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 304
14.5.5.1 Company footprint 304
14.5.5.2 Region footprint 304
14.5.5.3 Live animals footprint 305
14.5.5.4 Product and services footprint 306
14.5.5.5 Technology footprint 307
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 308
14.6.1 PROGRESSIVE COMPANIES 308
14.6.2 RESPONSIVE COMPANIES 308
14.6.3 DYNAMIC COMPANIES 308
14.6.4 STARTING BLOCKS 308
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES 310
14.6.5.1 Detailed list of key startups/SMEs 310
14.6.5.2 Competitive benchmarking of key startups/SMEs 311
14.7 COMPANY VALUATION AND FINANCIAL METRICS 312
14.7.1 FINANCIAL METRICS 312
14.7.2 COMPANY VALUATION 312
14.8 BRAND/PRODUCT COMPARISON 313
14.9 COMPETITIVE SCENARIO 314
14.9.1 PRODUCT LAUNCHES & APPROVALS 314
14.9.2 DEALS 316
14.9.3 EXPANSIONS 320
14.9.4 OTHER DEVELOPMENTS 322
15 COMPANY PROFILES 324
15.1 KEY PLAYERS 324
15.1.1 GENUS PLC 324
15.1.1.1 Business overview 324
15.1.1.2 Products/Service offered 325
15.1.1.3 Recent developments 326
15.1.1.3.1 Product/Service launches & approvals 326
15.1.1.3.2 Deals 326
15.1.1.3.3 Other developments 327
15.1.1.4 MnM view 327
15.1.1.4.1 Right to win 327
15.1.1.4.2 Strategic choices 328
15.1.1.4.3 Weaknesses and competitive threats 328
15.1.2 NEOGEN CORPORATION 329
15.1.2.1 Business overview 329
15.1.2.2 Products /Services offered 330
15.1.2.3 Recent developments 340
15.1.2.3.1 Product/Service launches and approvals 340
15.1.2.3.2 Deals 341
15.1.2.3.3 Expansions 341
15.1.2.4 MnM view 342
15.1.2.4.1 Right to win 342
15.1.2.4.2 Strategic choices 342
15.1.2.4.3 Weaknesses and competitive threats 342
15.1.3 EUROFINS SCIENTIFIC 343
15.1.3.1 Business overview 343
15.1.3.2 Products/Services offered 344
15.1.3.3 Recent developments 346
15.1.3.3.1 Deals 346
15.1.3.4 MnM view 347
15.1.3.4.1 Right to win 347
15.1.3.4.2 Strategic choices 347
15.1.3.4.3 Weaknesses and competitive threats 347
15.1.4 THERMO FISHER SCIENTIFIC INC 348
15.1.4.1 Business overview 348
15.1.4.2 Products/Services offered 349
15.1.4.3 Recent developments 352
15.1.4.3.1 Product/Services launches and approvals 352
15.1.4.4 MnM view 352
15.1.4.4.1 Right to win 352
15.1.4.4.2 Strategic choices 352
15.1.4.4.3 Weaknesses and competitive threats 352
15.1.5 ZOETIS SERVICES LLC 353
15.1.5.1 Business overview 353
15.1.5.2 Products/Services offered 355
15.1.5.3 Recent developments 356
15.1.5.3.1 Product & Service launches 356
15.1.5.3.2 Deals 357
15.1.5.3.3 Other developments 357
15.1.6 ILLUMINA, INC. 358
15.1.6.1 Business overview 358
15.1.6.2 Products/Services offered 359
15.1.7 HENDRIX GENETICS BV 362
15.1.7.1 Business overview 362
15.1.7.2 Products/Services offered 363
15.1.7.3 Recent developments 365
15.1.7.3.1 Product & Service launches 365
15.1.7.3.2 Deals 366
15.1.7.3.3 Expansions 367
15.1.7.3.4 Other developments 367
15.1.8 CRV 369
15.1.8.1 Business overview 369
15.1.8.2 Products/Services offered 369
15.1.8.3 Recent developments 370
15.1.8.3.1 Product/Services launches and approvals 370
15.1.8.3.2 Deals 370
15.1.9 TOPIGS NORSVIN EN 371
15.1.9.1 Business overview 371
15.1.9.2 Products/Services offered 371
15.1.9.3 Recent developments 372
15.1.9.3.1 Product/Service launches & approvals 372
15.1.9.3.2 Deals 373
15.1.9.3.3 Expansions 373
15.1.9.3.4 Other developments 373
15.1.10 URUS GROUP LP 374
15.1.10.1 Business overview 374
15.1.10.2 Products/Services offered 374
15.1.10.3 Recent developments 375
15.1.10.3.1 Product/Services launches and approvals 375
15.1.10.3.2 Deals 376
15.1.10.3.3 Expansions 376
15.1.10.4 MnM view 377
15.1.10.4.1 Right to win 377
15.1.10.4.2 Strategic choices 377
15.1.10.4.3 Weaknesses and competitive threats 377
15.1.11 SELECT SIRES INC. 378
15.1.11.1 Business overview 378
15.1.11.2 Products/Services offered 378
15.1.11.3 Recent developments 379
15.1.11.3.1 Product/Services launches and approvals 379
15.1.11.3.2 Deals 380
15.1.12 GROUPE GRIMAUD 381
15.1.12.1 Business overview 381
15.1.12.2 Products/Services offered 381
15.1.12.3 Recent developments 382
15.1.12.3.1 Expansions 382
15.1.12.3.2 Other developments 382
15.1.13 QUANTUM GENETIX/BIOSCIENCES 383
15.1.13.1 Business overview 383
15.1.13.2 Products/Services offered 383
15.1.13.3 Recent developments 384
15.1.13.3.1 Other developments 384
15.1.14 ANIMAL GENETICS, INC. 385
15.1.14.1 Business overview 385
15.1.14.2 Products/Services offered 385
15.1.15 SEMEX 390
15.1.15.1 Business overview 390
15.1.15.2 Products/Services offered 390
15.1.15.3 Recent developments 392
15.1.15.3.1 Deals 392
15.1.15.3.2 Expansions 393
15.2 OTHER PLAYERS 394
15.2.1 LABOKLIN GMBH & CO. KG 394
15.2.2 DANBRED P/S 395
15.2.3 TROPICAL ANIMAL GENETICS 396
15.2.4 INGURAN LLC DBA STGENETICS 397
15.2.5 SUPERIOR ANIMAL GENETICS 398
15.2.6 XYTOVET 399
15.2.7 SWINE GENETICS INTERNATIONAL 400
15.2.8 GENERATIO GMBH 401
15.2.9 GENSOL DIAGNOSTICS, LLC. 402
15.2.10 SANDOR ANIMAL BIOGENICS PVT. LTD. 403
16 RESEARCH METHODOLOGY 404
16.1 RESEARCH DATA 404
16.1.1 SECONDARY DATA 405
16.1.2 PRIMARY DATA 407
16.1.2.1 Breakdown of primary interviews 410
16.1.2.2 Key industry insights 411
16.2 MARKET SIZE ESTIMATION 411
16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH 412
16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 414
16.2.3 BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS 415
16.2.4 TOP-DOWN APPROACH 415
16.2.5 BASE NUMBER CALCULATION 416
16.2.5.1 Company presentations 416
16.2.5.2 Primary interviews 416
16.2.6 VOLUME ESTIMATION 416
16.2.7 DEMAND-SIDE APPROACH 417
16.3 MARKET BREAKDOWN AND DATA TRIANGULATION 421
16.4 MARKET SHARE ASSESSMENT 422
16.5 RESEARCH ASSUMPTIONS 422
16.5.1 STUDY ASSUMPTIONS 422
16.5.2 GROWTH RATE ASSUMPTIONS 423
16.6 RISK ASSESSMENT 423
16.6.1 RESEARCH LIMITATIONS 423
17 APPENDIX 424
17.1 DISCUSSION GUIDE 424
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 432
17.3 CUSTOMIZATION OPTIONS 434
17.4 RELATED REPORTS 434
17.5 AUTHOR DETAILS 435

LIST OF TABLES

TABLE 1 ANIMAL GENETICS MARKET: INCLUSIONS & EXCLUSIONS 36
TABLE 2 STANDARD CURRENCY CONVERSION RATES 37
TABLE 3 MILK PRODUCTION: PAST AND PROJECTED TRENDS IN DEVELOPING AND DEVELOPED COUNTRIES 48
TABLE 4 PER CAPITA CONSUMPTION OF MEAT: PAST AND PROJECTED TRENDS IN DEVELOPING AND DEVELOPED COUNTRIES 48
TABLE 5 WHITE SPACE OPPORTUNITIES IN ANIMAL GENETICS MARKET 57
TABLE 6 INTERCONNECTED MARKETS IN ANIMAL GENETICS MARKET 58
TABLE 7 CROSS SECTOR MARKETS IN ANIMAL GENETICS MARKET 58
TABLE 8 STRATEGIC MOVES BY TIER-1,2,3 PLAYERS IN ANIMAL GENETICS MARKET 59
TABLE 9 ANIMAL GENETICS MARKET: PORTER’S FIVE FORCES ANALYSIS 61
TABLE 10 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION) 64
TABLE 11 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, BY PRODUCT AND SERVICE MARKET (2023–2025) (USD) 72
TABLE 12 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY,
2023−2025 (USD) 73
TABLE 13 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END USER,
2023−2025 (USD) 74
TABLE 14 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023−2025 (USD) 75
TABLE 15 IMPORT DATA FOR HS CODE 050110, BY COUNTRY,
2021–2025 (USD THOUSAND) 76
TABLE 16 EXPORT DATA FOR HS CODE 051110, BY COUNTRY,
2021–2025 (USD THOUSAND) 76
TABLE 17 ANIMAL GENETICS MARKET: MAJOR CONFERENCES & EVENTS IN 2026–2027 77
TABLE 18 ACCELERATING DAIRY CATTLE GENETIC IMPROVEMENT
THROUGH GENOMIC TESTING 80
TABLE 19 IMPROVING SWINE PRODUCTIVITY THROUGH ADVANCED GENOMIC BREEDING 80
TABLE 20 ADVANCING POULTRY BREEDING THROUGH GENOMIC
SELECTION AND PHENOTYPING 81
TABLE 21 US ADJUSTED RECIPROCAL TARIFF RATES 81
TABLE 22 ASIA PACIFIC: IMPACT DUE TO THE US TARIFFS 83
TABLE 23 EUROPE: IMPACT DUE TO THE US TARIFFS 83
TABLE 24 ANIMAL GENETICS MARKET: MAJOR PATENTS 96
TABLE 25 KEY COMPANIES IMPLEMENTING AI IN ANIMAL GENETICS MARKET 99
TABLE 26 BEST PRACTICES IN ANIMAL GENETICS MARKET 100
TABLE 27 BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN
ANIMAL GENETICS MARKET 100
TABLE 28 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 101
TABLE 29 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 104
TABLE 30 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 105
TABLE 31 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 106
TABLE 32 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107
TABLE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL GENETIC PRODUCTS & SERVICES 115
TABLE 34 KEY BUYING CRITERIA FOR ANIMAL GENETICS MARKET, BY END USERS 117
TABLE 35 ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 122
TABLE 36 ANIMAL GENETICS MARKET FOR LIVE ANIMALS, BY COUNTRY,
2024–2031 (USD MILLION) 123
TABLE 37 BOVINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124
TABLE 38 PORCINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 39 CANINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 40 POULTRY GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 41 OTHER LIVE ANIMAL GENETICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 130
TABLE 42 ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 132
TABLE 43 ANIMAL GENETIC PRODUCTS & SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 133
TABLE 44 ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 134
TABLE 45 ANIMAL GENETIC MATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 46 ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION) 136
TABLE 47 ANIMAL GENETICS MARKET FOR SEMEN, BY COUNTRY,
2024–2031 (USD MILLION) 137
TABLE 48 CONVENTIONAL SEMEN VS. SEXED SEMEN: EVALUATION CRITERIA 138
TABLE 49 KEY PLAYERS OFFERING BOVINE SEMEN 138
TABLE 50 BOVINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 51 KEY PLAYERS OFFERING PORCINE SEMEN 140
TABLE 52 PORCINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 53 EQUINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 54 CANINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144
TABLE 55 ANIMAL GENETICS MARKET FOR OTHER ANIMAL SEMEN, BY COUNTRY,
2024–2031 (USD MILLION) 145
TABLE 56 ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION) 146
TABLE 57 ANIMAL GENETICS MARKET FOR EMBRYOS, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 58 ANIMAL GENETICS MARKET FOR BOVINE EMBRYOS, BY COUNTRY,
2024–2031 (USD MILLION) 148
TABLE 59 ANIMAL GENETICS MARKET FOR EQUINE EMBRYOS, BY COUNTRY,
2024–2031 (USD MILLION) 149
TABLE 60 ANIMAL GENETICS MARKET FOR OTHER ANIMAL EMBRYOS, BY COUNTRY,
2024–2031 (USD MILLION) 151
TABLE 61 ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 152
TABLE 62 ANIMAL GENETIC TESTING SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 153
TABLE 63 KEY GENETIC DISEASE TESTING SERVICES OFFERED, BY COMPANY 154
TABLE 64 GENETIC DISEASE TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 65 KEY GENETIC TRAIT TESTING SERVICES OFFERED, BY COMPANY 156
TABLE 66 GENETIC TRAIT TESTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 156
TABLE 67 GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 68 BOVINE GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 69 OTHER GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 70 KEY DNA TYPING SERVICES OFFERED, BY COMPANY 160
TABLE 71 ANIMAL DNA TYPING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161
TABLE 72 OTHER ANIMAL GENETICS SERVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 162
TABLE 73 ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 164
TABLE 74 ANIMAL GENETIC TECHNOLOGIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 165
TABLE 75 ANIMAL GENETICS MARKET FOR NGS (NEXT GENERATION SEQUENCING),
BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 76 ANIMAL GENETICS MARKET FOR PCR (POLYMERASE CHAIN REACTION),
BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 77 ANIMAL GENETICS MARKET FOR RDNA (RECOMBINANT DNA TECHNOLOGY),
BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 78 ANIMAL GENETICS MARKET FOR MICROARRAY, BY COUNTRY,
2024–2031 (USD MILLION) 170
TABLE 79 ANIMAL GENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY,
2024–2031 (USD MILLION) 171
TABLE 80 ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 174
TABLE 81 ANIMAL GENETICS MARKET, BY END USER, BY COUNTRY,
2024–2031 (USD MILLION) 175
TABLE 82 ANIMAL GENETICS MARKET FOR ANIMAL FARMS, BY COUNTRY,
2024–2031 (USD MILLION) 177
TABLE 83 ANIMAL GENETICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 84 ANIMAL GENETICS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY,
2024–2031 (USD MILLION) 180
TABLE 85 ANIMAL GENETICS MARKET FOR RESEARCH INSTITUTES, BY COUNTRY,
2024–2031 (USD MILLION) 182
TABLE 86 ANIMAL GENETICS MARKET, BY REGION, 2024–2031 (USD MILLION) 184
TABLE 87 NORTH AMERICA: ANIMAL GENETICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 186
TABLE 88 NORTH AMERICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 187
TABLE 89 NORTH AMERICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 187
TABLE 90 NORTH AMERICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 187
TABLE 91 NORTH AMERICA: BOVINE GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (UNITS) 188
TABLE 92 NORTH AMERICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 188
TABLE 93 NORTH AMERICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 188
TABLE 94 NORTH AMERICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 189
TABLE 95 NORTH AMERICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 189
TABLE 96 NORTH AMERICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 189
TABLE 97 NORTH AMERICA: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 190
TABLE 98 US: MACROECONOMIC INDICATORS 191
TABLE 99 US: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 191
TABLE 100 US: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 191
TABLE 101 US: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 102 US: ANIMAL GENETIC MATERIALS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 192
TABLE 103 US: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 192
TABLE 104 US: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 193
TABLE 105 US: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 193
TABLE 106 US: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 193
TABLE 107 US: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 194
TABLE 108 CANADA: MACROECONOMIC INDICATORS 195
TABLE 109 CANADA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 195
TABLE 110 CANADA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 195
TABLE 111 CANADA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 196
TABLE 112 CANADA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 196
TABLE 113 CANADA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 196
TABLE 114 CANADA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 197
TABLE 115 CANADA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 197
TABLE 116 CANADA: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 197
TABLE 117 CANADA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 198
TABLE 118 EUROPE: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199
TABLE 119 EUROPE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 200
TABLE 120 EUROPE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 200
TABLE 121 EUROPE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 200
TABLE 122 EUROPE: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS) 201
TABLE 123 EUROPE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 201
TABLE 124 EUROPE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 201
TABLE 125 EUROPE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 202
TABLE 126 EUROPE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 202
TABLE 127 EUROPE: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 202
TABLE 128 EUROPE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 203
TABLE 129 GERMANY: MACROECONOMIC INDICATORS 203
TABLE 130 GERMANY: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 204
TABLE 131 GERMANY: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 204
TABLE 132 GERMANY: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 204
TABLE 133 GERMANY: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 134 GERMANY: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 135 GERMANY: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 136 GERMANY: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 206
TABLE 137 GERMANY: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 206
TABLE 138 GERMANY: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 206
TABLE 139 UK: MACROECONOMIC INDICATORS 207
TABLE 140 UK: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 207
TABLE 141 UK: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 208
TABLE 142 UK: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 143 UK: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 144 UK: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 209
TABLE 145 UK: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 209
TABLE 146 UK: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 209
TABLE 147 UK: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 210
TABLE 148 UK: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 210
TABLE 149 FRANCE: MACROECONOMIC INDICATORS 211
TABLE 150 FRANCE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 211
TABLE 151 FRANCE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 212
TABLE 152 FRANCE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 212
TABLE 153 FRANCE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 212
TABLE 154 FRANCE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 213
TABLE 155 FRANCE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 213
TABLE 156 FRANCE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 213
TABLE 157 FRANCE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 214
TABLE 158 FRANCE: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 214
TABLE 159 FRANCE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 214
TABLE 160 ITALY: MACROECONOMIC INDICATORS 215
TABLE 161 ITALY: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 215
TABLE 162 ITALY: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 216
TABLE 163 ITALY: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 216
TABLE 164 ITALY: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 216
TABLE 165 ITALY: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 217
TABLE 166 ITALY: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 217
TABLE 167 ITALY: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 217
TABLE 168 ITALY: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 218
TABLE 169 ITALY: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 218
TABLE 170 SPAIN: MACROECONOMIC INDICATORS 219
TABLE 171 SPAIN: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 219
TABLE 172 SPAIN: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 219
TABLE 173 SPAIN: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 174 SPAIN: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 175 SPAIN: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 176 SPAIN: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 221
TABLE 177 SPAIN: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 221
TABLE 178 SPAIN: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 221
TABLE 179 SPAIN: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 222
TABLE 180 NETHERLANDS: MACROECONOMIC INDICATORS 222
TABLE 181 NETHERLANDS: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 223
TABLE 182 NETHERLANDS: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 223
TABLE 183 NETHERLANDS: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 223
TABLE 184 NETHERLANDS: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 185 NETHERLANDS: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 186 NETHERLANDS: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 187 NETHERLANDS: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 225
TABLE 188 NETHERLANDS: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 225
TABLE 189 NETHERLANDS: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 225
TABLE 190 REST OF EUROPE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 226
TABLE 191 REST OF EUROPE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 226
TABLE 192 REST OF EUROPE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 227
TABLE 193 REST OF EUROPE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 227
TABLE 194 REST OF EUROPE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 227
TABLE 195 REST OF EUROPE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 228
TABLE 196 REST OF EUROPE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 228
TABLE 197 REST OF EUROPE: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 228
TABLE 198 REST OF EUROPE: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 229
TABLE 199 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 231
TABLE 200 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 231
TABLE 201 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 231
TABLE 202 ASIA PACIFIC: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 232
TABLE 203 ASIA PACIFIC: BOVINE GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (UNITS) 232
TABLE 204 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 205 ASIA PACIFIC: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 206 ASIA PACIFIC: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 207 ASIA PACIFIC: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 208 ASIA PACIFIC: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 234
TABLE 209 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 234
TABLE 210 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 234
TABLE 211 CHINA: MACROECONOMIC INDICATORS 235
TABLE 212 CHINA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 236
TABLE 213 CHINA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 236
TABLE 214 CHINA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 215 CHINA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 216 CHINA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 217 CHINA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 218 CHINA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 238
TABLE 219 CHINA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 238
TABLE 220 CHINA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 238
TABLE 221 INDIA: MACROECONOMIC INDICATORS 239
TABLE 222 INDIA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 240
TABLE 223 INDIA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 240
TABLE 224 INDIA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 240
TABLE 225 INDIA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 226 INDIA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 227 INDIA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 228 INDIA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 242
TABLE 229 INDIA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 242
TABLE 230 INDIA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 242
TABLE 231 JAPAN: MACROECONOMIC INDICATORS 243
TABLE 232 JAPAN: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 243
TABLE 233 JAPAN: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 244
TABLE 234 JAPAN: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 244
TABLE 235 JAPAN: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 244
TABLE 236 JAPAN: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 237 JAPAN: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 238 JAPAN: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 245
TABLE 239 JAPAN: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 246
TABLE 240 JAPAN: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 246
TABLE 241 AUSTRALIA: MACROECONOMIC INDICATORS 247
TABLE 242 AUSTRALIA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 247
TABLE 243 AUSTRALIA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 247
TABLE 244 AUSTRALIA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 248
TABLE 245 AUSTRALIA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 248
TABLE 246 AUSTRALIA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 248
TABLE 247 AUSTRALIA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 249
TABLE 248 AUSTRALIA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 249
TABLE 249 AUSTRALIA: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 249
TABLE 250 AUSTRALIA: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 250
TABLE 251 SOUTH KOREA: MACROECONOMIC INDICATORS 250
TABLE 252 SOUTH KOREA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 251
TABLE 253 SOUTH KOREA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 251
TABLE 254 SOUTH KOREA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 251
TABLE 255 SOUTH KOREA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 252
TABLE 256 SOUTH KOREA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 252
TABLE 257 SOUTH KOREA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 252
TABLE 258 SOUTH KOREA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 253
TABLE 259 SOUTH KOREA: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 253
TABLE 260 SOUTH KOREA: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 253
TABLE 261 REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 254
TABLE 262 REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 254
TABLE 263 REST OF ASIA PACIFIC: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 264 REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 265 REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 266 REST OF ASIA PACIFIC: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 267 REST OF ASIA PACIFIC: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 256
TABLE 268 REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 256
TABLE 269 REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 257
TABLE 270 LATIN AMERICA: ANIMAL GENETICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 258
TABLE 271 LATIN AMERICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 258
TABLE 272 LATIN AMERICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 258
TABLE 273 LATIN AMERICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 259
TABLE 274 LATIN AMERICA: BOVINE GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (UNITS) 259
TABLE 275 LATIN AMERICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 259
TABLE 276 LATIN AMERICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 260
TABLE 277 LATIN AMERICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 260
TABLE 278 LATIN AMERICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 260
TABLE 279 LATIN AMERICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 261
TABLE 280 LATIN AMERICA: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 261
TABLE 281 BRAZIL: MACROECONOMIC INDICATORS 262
TABLE 282 BRAZIL: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 262
TABLE 283 BRAZIL: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 262
TABLE 284 BRAZIL: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 263
TABLE 285 BRAZIL: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 263
TABLE 286 BRAZIL: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 263
TABLE 287 BRAZIL: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 288 BRAZIL: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 264
TABLE 289 BRAZIL: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 264
TABLE 290 BRAZIL: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 265
TABLE 291 MEXICO: MACROECONOMIC INDICATORS 266
TABLE 292 MEXICO: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 266
TABLE 293 MEXICO: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 266
TABLE 294 MEXICO: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 295 MEXICO: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 296 MEXICO: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 297 MEXICO: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 268
TABLE 298 MEXICO: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 268
TABLE 299 MEXICO: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 268
TABLE 300 MEXICO: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 269
TABLE 301 REST OF LATIN AMERICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 269
TABLE 302 REST OF LATIN AMERICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 270
TABLE 303 REST OF LATIN AMERICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 304 REST OF LATIN AMERICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 305 REST OF LATIN AMERICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 306 REST OF LATIN AMERICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 307 REST OF LATIN AMERICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 271
TABLE 308 REST OF LATIN AMERICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 272
TABLE 309 REST OF LATIN AMERICA: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 272
TABLE 310 MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY REGION,
2024–2031 (USD MILLION) 273
TABLE 311 MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 274
TABLE 312 MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 274
TABLE 313 MIDDLE EAST & AFRICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 274
TABLE 314 MIDDLE EAST & AFRICA: BOVINE GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (UNITS) 275
TABLE 315 MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 316 MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 317 MIDDLE EAST & AFRICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 318 MIDDLE EAST & AFRICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 276
TABLE 319 MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 276
TABLE 320 MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 277
TABLE 321 GCC COUNTRIES: ANIMAL GENETICS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 277
TABLE 322 GCC COUNTRIES: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 278
TABLE 323 GCC COUNTRIES: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE,
2024–2031 (USD MILLION) 278
TABLE 324 GCC COUNTRIES: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 278
TABLE 325 GCC COUNTRIES: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE,
2024–2031 (USD MILLION) 279
TABLE 326 GCC COUNTRIES: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE,
2024–2031 (USD MILLION) 279
TABLE 327 GCC COUNTRIES: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 279
TABLE 328 GCC COUNTRIES: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 280
TABLE 329 GCC COUNTRIES: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 280
TABLE 330 GCC COUNTRIES: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 280
TABLE 331 KINGDOM OF SAUDI ARABIA: MACROECONOMIC INDICATORS 281
TABLE 332 KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 281
TABLE 333 KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET,
BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 282
TABLE 334 KINGDOM OF SAUDI ARABIA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 335 KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 336 KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 337 KINGDOM OF SAUDI ARABIA: ANIMAL GENETIC TESTING SERVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 338 KINGDOM OF SAUDI ARABIA: ANIMAL GENETIC TRAIT TESTS MARKET,
BY LIVE ANIMAL, 2024–2031 (USD MILLION) 283
TABLE 339 KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 284
TABLE 340 KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 284
TABLE 341 UNITED ARAB EMIRATES: MACROECONOMIC INDICATORS 285
TABLE 342 UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 285
TABLE 343 UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 285
TABLE 344 UNITED ARAB EMIRATES: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 286
TABLE 345 UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 346 UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 347 UNITED ARAB EMIRATES: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 348 UNITED ARAB EMIRATES: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 287
TABLE 349 UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 287
TABLE 350 UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 288
TABLE 351 REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET, BY LIVE ANIMAL,
2024–2031 (USD MILLION) 288
TABLE 352 REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 289
TABLE 353 REST OF GCC COUNTRIES: ANIMAL GENETIC MATERIALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 289
TABLE 354 REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 355 REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 356 REST OF GCC COUNTRIES: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 357 REST OF GCC COUNTRIES: ANIMAL GENETIC TRAIT TESTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 358 REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 291
TABLE 359 REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET, BY END USER,
2024–2031 (USD MILLION) 291
TABLE 360 REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION) 292
TABLE 361 REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET,
BY PRODUCT & SERVICE, 2024–2031 (USD MILLION) 292
TABLE 362 REST OF MIDDLE EAST & AFRICA: ANIMAL GENETIC MATERIALS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 292
TABLE 363 REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET FOR SEMEN,
BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 364 REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET FOR EMBRYOS,
BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 365 REST OF MIDDLE EAST & AFRICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 366 REST OF MIDDLE EAST & AFRICA: ANIMAL GENETIC TRAIT TESTS MARKET,
BY LIVE ANIMAL, 2024–2031 (USD MILLION) 294
TABLE 367 REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 294
TABLE 368 REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION) 294
TABLE 369 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ANIMAL GENETICS MARKET, JANUARY 2023–JUNE 2026 296
TABLE 370 ANIMAL GENETICS MARKET: DEGREE OF COMPETITION, 2025 298
TABLE 371 US ANIMAL GENETICS MARKET: DEGREE OF COMPETITION, 2025 300
TABLE 372 EUROPE: ANIMAL GENETICS MARKET: DEGREE OF COMPETITION, 2025 301
TABLE 373 ANIMAL GENETICS MARKET: REGION FOOTPRINT 304
TABLE 374 ANIMAL GENETICS MARKET: LIVE ANIMALS FOOTPRINT 305
TABLE 375 ANIMAL GENETICS MARKET: PRODUCT AND SERVICES FOOTPRINT 306
TABLE 376 ANIMAL GENETICS MARKET: TECHNOLOGY FOOTPRINT 307
TABLE 377 ANIMAL GENETICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025 310
TABLE 378 ANIMAL GENETICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS, 2025 311
TABLE 379 ANIMAL GENETICS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JUNE 2026 314
TABLE 380 ANIMAL GENETICS MARKET: DEALS, JANUARY 2023–JUNE 2026 316
TABLE 381 ANIMAL GENETICS MARKET: EXPANSIONS, JANUARY 2023–JUNE 2026 320
TABLE 382 ANIMAL GENETICS MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JUNE 2026 322
TABLE 383 GENUS PLC: COMPANY OVERVIEW 324
TABLE 384 GENUS PLC: PRODUCTS/SERVICES OFFERED 325
TABLE 385 GENUS PLC: PRODUCT/SERVICE LAUNCHES & APPROVALS 326
TABLE 386 GENUS PLC: DEALS 326
TABLE 387 GENUS PLC: OTHER DEVELOPMENTS 327
TABLE 388 NEOGEN CORPORATION: COMPANY OVERVIEW 329
TABLE 389 NEOGEN CORPORATION: PRODUCTS/SERVICES OFFERED 330
TABLE 390 NEOGEN CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS 340
TABLE 391 NEOGEN CORPORATION: DEALS 341
TABLE 392 NEOGEN CORPORATION: EXPANSIONS 341
TABLE 393 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 343
TABLE 394 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 344
TABLE 395 EUROFINS SCIENTIFIC: DEALS 346
TABLE 396 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 348
TABLE 397 THERMO FISHER SCIENTIFIC INC: PRODUCTS/SERVICES OFFERED 349
TABLE 398 THERMO FISHER SCIENTIFIC INC: PRODUCT/SERVICE LAUNCHES & APPROVALS 352
TABLE 399 ZOETIS SERVICES LLC: COMPANY OVERVIEW 353
TABLE 400 ZOETIS: PRODUCTS/SERVICES OFFERED 355
TABLE 401 ZOETIS SERVICES LLC: PRODUCT & SERVICE LAUNCHES 356
TABLE 402 ZOETIS SERVICES LLC: DEALS 357
TABLE 403 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS 357
TABLE 404 ILLUMINA, INC.: COMPANY OVERVIEW 358
TABLE 405 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED 359
TABLE 406 HENDRIX GENETICS BV: COMPANY OVERVIEW 362
TABLE 407 HENDRIX GENETICS BV: PRODUCTS/SERVICES OFFERED 363
TABLE 408 HENDRIX GENETICS BV: PRODUCT & SERVICE LAUNCHES 365
TABLE 409 HENDRIX GENETICS BV: DEALS 366
TABLE 410 HENDRIX GENETICS BV: EXPANSIONS 367
TABLE 411 HENDRIX GENETICS BV: OTHER DEVELOPMENTS 367
TABLE 412 CRV: COMPANY OVERVIEW 369
TABLE 413 CRV: PRODUCTS/SERVICES OFFERED 369
TABLE 414 CRV: PRODUCT/SERVICE LAUNCHES & APPROVALS 370
TABLE 415 CRV: DEALS 370
TABLE 416 TOPIGS NORSVIN EN: COMPANY OVERVIEW 371
TABLE 417 TOPIGS NORSVIN EN: PRODUCTS/SERVICES OFFERED 371
TABLE 418 TOPIGS NORSVIN EN: PRODUCT/SERVICE LAUNCHES & APPROVALS 372
TABLE 419 TOPIGS NORSVIN EN: DEALS 373
TABLE 420 TOPIGS NORSVIN EN: EXPANSIONS 373
TABLE 421 TOPIGS NORSVIN EN: OTHER DEVELOPMENTS 373
TABLE 422 URUS GROUP LP: COMPANY OVERVIEW 374
TABLE 423 URUS GROUP LP: PRODUCTS/SERVICES OFFERED 374
TABLE 424 URUS GROUP LP: PRODUCT/SERVICE LAUNCHES & APPROVALS 375
TABLE 425 URUS GROUP LP: DEALS 376
TABLE 426 URUS GROUP LP: EXPANSIONS 376
TABLE 427 SELECT SIRES INC.: COMPANY OVERVIEW 378
TABLE 428 SELECT SIRES INC: PRODUCTS/SERVICES OFFERED 378
TABLE 429 SELECT SIRES INC: PRODUCT/SERVICE LAUNCHES & APPROVALS 379
TABLE 430 SELECT SIRES INC.: DEALS 380
TABLE 431 GROUPE GRIMAUD: COMPANY OVERVIEW 381
TABLE 432 GROUPE GRIMAUD: PRODUCTS/SERVICES OFFERED 381
TABLE 433 GROUPE GRIMAUD: EXPANSIONS 382
TABLE 434 GROUPE GRIMAUD: OTHER DEVELOPMENTS 382
TABLE 435 QUANTUM GENETIX/BIOSCIENCES: COMPANY OVERVIEW 383
TABLE 436 QUANTUM GENETIX/BIOSCIENCES: PRODUCTS/SERVICES OFFERED 383
TABLE 437 QUANTUM GENETIX/BIOSCIENCES: OTHER DEVELOPMENTS 384
TABLE 438 ANIMAL GENETICS INC.: COMPANY OVERVIEW 385
TABLE 439 ANIMAL GENETICS INC.: PRODUCTS/SERVICES OFFERED 385
TABLE 440 SEMEX: COMPANY OVERVIEW 390
TABLE 441 SEMEX: PRODUCTS/SERVICES OFFERED 390
TABLE 442 SEMEX: DEALS 392
TABLE 443 SEMEX: EXPANSIONS 393
TABLE 444 STUDY ASSUMPTIONS 422
TABLE 445 ANIMAL GENETICS MARKET: RISK ASSESSMENT ANALYSIS 423

LIST OF FIGURES

FIGURE 1 ANIMAL GENETICS MARKET: SEGMENTS CONSIDERED 35
FIGURE 2 MARKET SCENARIO 39
FIGURE 3 GLOBAL ANIMAL GENETICS MARKET, 2024–2031 40
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ANIMAL GENETICS MARKET, 2024–2026 40
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF ANIMAL GENETICS MARKET 41
FIGURE 6 HIGH-GROWTH SEGMENTS IN ANIMAL GENETICS MARKET, 2026–2031 42
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN ANIMAL GENETICS MARKET,
IN TERMS OF VALUE, DURING FORECAST PERIOD 43
FIGURE 8 GROWING ADOPTION OF GENETIC TESTING TO DRIVE MARKET GROWTH 44
FIGURE 9 ANIMAL FARMS SEGMENT IN ASIA PACIFIC REGION ACCOUNTED
FOR LARGEST SHARE IN 2025 45
FIGURE 10 INDIA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 46
FIGURE 11 ANIMAL GENETICS MARKET: MARKET DYNAMICS 47
FIGURE 12 ANIMAL GENETICS MARKET: PORTER’S FIVE FORCES ANALYSIS 62
FIGURE 13 SUPPLY CHAIN ANALYSIS 69
FIGURE 14 ANIMAL GENETICS PRODUCT AND SERVICE MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS 71
FIGURE 15 ANIMAL GENETICS MARKET: ECOSYSTEM ANALYSIS 72
FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78
FIGURE 17 INVESTMENT & FUNDING SCENARIO, 2023–2026 79
FIGURE 18 ANIMAL GENETICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS, JANUARY 2016–MAY 2026 94
FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR ANIMAL GENETIC PRODUCTS& SERVICES PATENTS, JANUARY 2016–JUNE 2026 95
FIGURE 20 KEY FEATURES OF AI/GENERATIVE AI IN ANIMAL GENETICS MARKET 99
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL GENETIC PRODUCTS & SERVICES 114
FIGURE 22 KEY BUYING CRITERIA FOR ANIMAL GENETICS MARKET, BY END USER 116
FIGURE 23 NORTH AMERICA: ANIMAL GENETICS MARKET SNAPSHOT 186
FIGURE 24 ASIA PACIFIC: ANIMAL GENETICS MARKET SNAPSHOT 230
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN ANIMAL GENETICS MARKET,
2023–2025 (USD MILLION) 297
FIGURE 26 GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 298
FIGURE 27 US: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET, 2025 300
FIGURE 28 EUROPE: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET, 2025 301
FIGURE 29 ANIMAL GENETICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 303
FIGURE 30 ANIMAL GENETICS MARKET: COMPANY FOOTPRINT, 2025 304
FIGURE 31 ANIMAL GENETICS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2025 309
FIGURE 32 EV/EBITDA OF KEY VENDORS FOR ANIMAL GENETICS, 2025 312
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR ANIMAL GENETICS, 2025 312
FIGURE 34 ANIMAL GENETICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 313
FIGURE 35 GENUS PLC: COMPANY SNAPSHOT (2025) 325
FIGURE 36 NEOGEN CORPORATION: COMPANY SNAPSHOT (2025) 330
FIGURE 37 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025) 344
FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 349
FIGURE 39 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2025) 354
FIGURE 40 ILLUMINA, INC.: COMPANY SNAPSHOT (2025) 359
FIGURE 41 ANIMAL GENETICS MARKET: RESEARCH DESIGN 404
FIGURE 42 KEY DATA FROM SECONDARY SOURCES 407
FIGURE 43 PRIMARY SOURCES 408
FIGURE 44 KEY DATA FROM PRIMARY SOURCES 409
FIGURE 45 KEY INDUSTRY INSIGHTS 409
FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 410
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 410
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS 411
FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 412
FIGURE 50 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 413
FIGURE 51 REVENUE SHARE ANALYSIS ILLUSTRATION: GENUS PLC (2025) 414
FIGURE 52 BOTTOM-UP APPROACH 415
FIGURE 53 TOP-DOWN APPROACH 415
FIGURE 54 SUPPLY-SIDE ANALYSIS: ANIMAL GENETICS MARKET (2025) 416
FIGURE 55 DEMAND-SIDE APPROACH 418
FIGURE 56 ANIMAL GENETICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031) 419
FIGURE 57 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 420
FIGURE 58 MARKET DATA TRIANGULATION METHODOLOGY 421

---

---